Search results :

Atomoxetine

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: N06BA09

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Dry mouth 1% - 21% 1% - 7% x x x x x x x x x x x x x x x
Abdominal pain upper very common, 16% - 20% 9% - 16% x x x x x x x x x x
Headache very common, 3% - 27% 1% - 25% x x x x x x x x x x x x x x x
Abdominal pain very common, 7% - 18% 4% - 13% x x x x x x x x x
Middle insomnia common, 4% - 16% 1% - 8% x x x x x x x x x x x x
Tachycardia very common x x x x x x x x x x
Abdominal discomfort very common x x x x
Upset stomach very common x x x x
Blood pressure increased postmarketing, very common x x x x x x x x x x
Epigastric discomfort very common x x x x
Insomnia common, 13% - 16% 6% - 8% x x x x x x x x x x x x x x x
Decreased appetite 10% - 16% 2% - 6% x x x x x x x x x x x x x x x
Nausea very common, 7% - 26% 2% - 8% x x x x x x x x x x x x x x x
Cough 11% 7% x x x x x x
Vomiting very common, 3% - 15% 1% - 9% x x x x x x x x x x x x x x x
Fatigue common, 4% - 10% 1% - 6% x x x x x x x x x x x x x x x
Strangury 2% - 8% 0% x x x x x x x
Somnolence very common, 4% - 11% 3% - 5% x x x x x x x x x x x x x x x
Erectile dysfunction 3% - 9% 0% - 1% x x x x x x x x x x x x x x x
Dizziness 5% - 8% 2% - 4% x x x x x x x x x x x x x x x
Dysmenorrhoea 3% - 7% 2% - 3% x x x x x x x x x x x x x x x
Irritability common, 5% - 8% 3% - 5% x x x x x x x x x x x x x x x
Sinusitis 6% 4% x x x x x x
Vertigo 6% 3% x x x x x x
Urinary hesitation postmarketing, 3% - 8% 0% - 1% x x x x x x x x x x x x x x x
Mydriasis common x
Pruritus common x x x x x x x x x x
Urinary retention postmarketing, 3% - 8% 0% - 1% x x x x x x x x x x x x x x x
Depressive symptom common x x x x x x x x
Dysphoria common x x x x x x x x
Ejaculation failure 5% 2% x x x x x x x
Initial insomnia common x x x x
Terminal insomnia common x x x x x x x x x x x x x x x
Major depression common x x x x x x x x
Libido decreased 3% - 6% 1% - 2% x x x x x x x x x x x x x x x
Dermatitis 2% - 4% 1% - 2% x x x x x x x
Dyspepsia 4% - 8% 0% - 4% x x x x x x x x x x x x x x x
Hyperhidrosis postmarketing, 4% 1% x x x x x x x x x
Abnormal dreams 4% 3% x x x x x x x x
Ejaculation disorder 3% - 5% 1% - 2% x x x x x x x x x x x x x x x
Sweating increased 4% 1% x x x x x x
Rhinorrhoea 4% 3% x x x x x x
Diarrhoea 3% - 4% 1% - 6% x x x x x x
Anorexia common, 3% 1% x x x x x x x x x x x x x x x
Dysuria 2% - 3% 0% x x x x x x x x
Body temperature increased postmarketing, 3% 2% x x x x x x x
Influenza 2% - 3% 1% x x x x x x x
Menstrual disorder 3% 2% x x x x x x
Palpitations uncommon, 3% - 4% 1% x x x x x x x x x x x x x x x
Paraesthesia postmarketing, 3% - 4% 0% - 2% x x x x x x x x x x x x x x
Prostatitis 3% 0% x x x x x x x x x x
Sinus headache 3% 1% x x x x x x x x x x x x
Chills 3% 0% - 1% x x x x x x x x x
Myalgia 3% 2% x x x x x x
Ejaculation delayed 3% - 4% 1% x x x x x x x x
Rigors 3% 1% x x x x x x x
Hot flush 3% - 8% 0% - 1% x x x x x x x x x x x x x x x
Ear infection 3% 1% x x x x x x
Sleep disorder 3% - 4% 1% - 2% x x x x x x x x x x x x x x x
Constipation 0% - 10% 0% - 4% x x x x x x x x x x x x x x x
Rash common, 2% 1% x x x x x x x x x
Flatulence 2% 1% x x x x x x x x
Orgasm abnormal 2% 1% x x x x x x x x x x
Thirst 2% 1% x x x
Tremor uncommon, 2% 0% x x x x x x x x x x x x x x x
Weight decreased common, 2% - 3% 0% - 1% x x x x x x x x x x x x x x x
Mood swings 1% - 5% 0% - 2% x x x x x x x x x x x x x x x
Menstruation irregular 2% 0% x x x x x x x x x x x x x
Menstruation delayed 2% 1% x x x x x x
Feeling jittery 2% 0% - 1% x x x x x x x x x
Therapeutic response unexpected 2% - 3% 1% x x x x x x x x
Asthenia uncommon x x x x
Conjunctivitis uncommon x x x x x x x x x
Flushing uncommon x x x x x x x x x x
Sinus tachycardia uncommon x x x x x x x x x x
Syncope vasovagal uncommon x
Aggression postmarketing x x x x x x x x x x x x x x x
Anxiety postmarketing x x x x x x x x x
Mental disorder postmarketing x x x x x x
Coma postmarketing x
Delirium postmarketing x
Depression postmarketing x x x x x x x
Hallucination postmarketing x x
Hostility postmarketing x
Hypoaesthesia postmarketing x x x x x x x
Lethargy postmarketing, 7% 4% x x x x x x x x x x x x x x
Muscle rigidity postmarketing x
Myoclonus postmarketing x
Nervous system disorder postmarketing x x x x x x x x x x x x x x x
Neuroleptic malignant syndrome postmarketing x
Pelvic pain postmarketing x x x x x x x x
Psychotic disorder postmarketing x
Convulsion postmarketing x x x x x x x x x x x
Suicide attempt postmarketing x
Syncope very rare — uncommon x x x x x x x x x x x x x
Angiopathy postmarketing x x x x x x x x x x x x x x x
Agitation postmarketing x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x x x x x x x x x
Autonomic nervous system imbalance postmarketing x
Mania postmarketing x
Depressed mood postmarketing, common x x x x x x x x
Suicidal ideation postmarketing x
Genital pain male postmarketing x
Drug interaction postmarketing x
Completed suicide postmarketing x
Mental status changes postmarketing x
Erection prolonged postmarketing x
Pre-existing disease very rare, postmarketing x x
Arthralgia x x x x x x
Back pain x x x x x x
Bone disorder x x x x x x
Breast disorder x x x x x x x x x x x x x x x
Chest pain x x x x x x x x x x x x x x
Infection x x x x x x x
Drug abuse x x
Dysgeusia x
Excoriation x x x x x x x x
Gastrointestinal disorder x x x x x x x x x x x x x x x
Cardiac disorder x x x x x x x x x x x x x x x
Mediastinal disorder x x x x x x
Nasal congestion x x x x x x
Nasopharyngitis x x x x x x
Nervousness x x x x x x x x
Pain x
Muscle spasms x
Testicular pain x x x x
Upper respiratory tract infection x x x x x x
Urinary tract disorder x x x x x x x x x x x x x x x
Urticaria x
Micturition urgency x
Sinus congestion x x x x x x
Viral diarrhoea x x x x x x
Malnutrition x x x x x x x x x x x x x x x
Disorientation x
Abnormal behaviour x x
Throat sore x x x x x x
Peripheral coldness x x x x x x x x x x x x
Dependence psychological x x
Vision blurred x x x
Tearfulness x x x x x x
Gastrointestinal symptom NOS x x
Dependence x x
Urine flow decreased x
Sexual dysfunction x x x x x x x x x x x x x x
Infestation NOS x x
Pharyngolaryngeal pain x x x
Female sexual dysfunction x x x x x x x x x x x x x x
Hepatic insufficiency x x
Feeling abnormal x x x x x x x x
Suicidal behaviour x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Atomoxetine Hydrochloride / Strattera

Side effects:83
Source:FDA

ATOMOXETINE HYDROCHLORIDE / STRATTERA

Side effects:84
Source:FDA

atomoxetine HCl / Strattera

Side effects:84
Source:FDA

ATOMOXETINE HYDROCHLORIDE / STRATTERA

Side effects:84
Source:FDA

atomoxetine hydrochloride / Strattera

Side effects:89
Source:FDA

atomoxetine HCl / Strattera

Side effects:93
Source:FDA

ATOMOXETINE

Side effects:59
Source:FDA Structured Product Label

Atomoxetine

Side effects:65
Source:FDA Structured Product Label

ATOMOXETINE

Side effects:65
Source:FDA Structured Product Label

Atomoxetine

Side effects:68
Source:FDA Structured Product Label

Atomoxetine

Side effects:68
Source:FDA Structured Product Label

ATOMOXETINE

Side effects:82
Source:FDA Structured Product Label

ATOMOXETINE

Side effects:83
Source:FDA Structured Product Label

atomoxetine hydrochloride / Strattera

Side effects:88
Source:FDA

Atomoxetine capsules / Strattera, Capsule

Side effects:96
Source:Medsafe

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label